Sign in
8-K

Current Report

Cartesian Therapeutics, Inc. Filed Acc 0001453687-19-000002

Exit or restructuring costs · Regulation FD disclosure · Other events

  • Item 2.05 Costs associated with exit or disposal activities
  • Item 7.01 Regulation FD disclosure
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading selectabiosciences8k_reorg.htm…